Potential to revolutionize HIV prevention. Ethel Weld, an Assistant Professor of Medicine at Johns Hopkins University School ...

There's a catch, however: Given as either a pill or injection and currently branded as Sunlenca, lenacapavir as treatment for ...

Lenacapavir, a new HIV prevention drug ... been authorized by the U.S. Food and Drug Administration for the treatment of HIV infection in adults, in combination with other medicines.

Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against ...

Researchers at Université de Montréal's affiliated hospital research center, the CRCHUM, say the discovery could help lessen ...

Twice-a-year-PReP will only fulfill its potential if Medicaid takes decisive action to ensure it is accessible to the ...

HIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Young people living with HIV play a critical role in the fight against AIDS in communities. They offer support and share ...

The largest-ever study of women in sub-Saharan Africa zeroes in on the combination of bacterial vaginosis-associated bacteria ...

Contrary to popular belief, HIV remains a serious public health concern in Canada. New HIV diagnoses rose by a startling 25% ...

The Joint United Nations Programme on HIV/AIDS (UNAIDS) has raised alarm over the increasing incidence of HIV among young ...